
Livzon Pharmaceutical Group Co., Ltd. (A+H Share Listed, A-share: 000513, H-share: 01513), established in January 1985, is a leading integrated pharmaceutical conglomerate specializing in R&D, production, and commercialization. With expertise spanning APIs, chemical drugs, traditional Chinese medicine, biologics, and in vitro diagnostics, its products target high-demand therapeutic areas including gastroenterology, cardiovascular/cerebrovascular diseases, reproductive endocrinology, and neuropsychiatry. The Group operates 3 national-level R&D centers and 8 provincial-level R&D hubs, driving innovation in sustained-release microspheres, biologics, and novel drug discovery. Livzon Group's Mission: PATIENT QUALITY OF LIFE COMES FIRST. Livzon Group's Vision: BE THE PHARMACEUTICAL INDUSTRY LEADER . PT Livzon Pharma Indonesia is a joint venture established by Livzon Group, one of China's top three API (Active Pharmaceutical Ingredient) companies, and Kalbe, Indonesia's largest pharmaceutical company.

China (HQ Training) / Indonesia
China (HQ Training) / Indonesia
China (HQ Training) / Indonesia
China (HQ Training) / Indonesia
China (HQ Training) / Indonesia